Literature DB >> 8147261

A note on the effect of sulphidopeptide leukotrienes on granulocytes in asthma.

M K Thomsen, I Ahnfelt-Rønne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8147261     DOI: 10.1007/bf01976743

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


× No keyword cloud information.
  7 in total

Review 1.  The role of neutrophil-activating mediators in canine health and disease (with special reference to the role of leukotrienes in inflammatory dermatoses).

Authors:  M Krogsgaard Thomsen
Journal:  J Vet Pharmacol Ther       Date:  1991-06       Impact factor: 1.786

2.  Leukocyte recognition and metabolism of leukotrienes.

Authors:  E J Goetzl
Journal:  Fed Proc       Date:  1983-11

3.  LTD4 increases cytosolic free calcium and inositol phosphates in human neutrophils: inhibition by the novel LTD4 receptor antagonist, SR2640, and possible relation to modulation of chemotaxis.

Authors:  P N Bouchelouche; I Ahnfelt-Rønne; M K Thomsen
Journal:  Agents Actions       Date:  1990-03

4.  Inhibition by the LTD4 antagonist, SR2640, of effects of LTD4 on canine polymorphonuclear leukocyte functions.

Authors:  M K Thomsen; I Ahnfelt-Rønne
Journal:  Biochem Pharmacol       Date:  1989-07-15       Impact factor: 5.858

5.  Leukotriene E4 and granulocytic infiltration into asthmatic airways.

Authors:  L A Laitinen; A Laitinen; T Haahtela; V Vilkka; B W Spur; T H Lee
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

6.  Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.

Authors:  Y H Atkinson; W A Marasco; A F Lopez; M A Vadas
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

7.  Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.

Authors:  R D Camp; A A Coutts; M W Greaves; A B Kay; M J Walport
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.